Patients with insulin-dependent diabetes (IDDM) possess antibodies to islet proteins of M,-64,000. Potential autoantigens of this Mr include glutamate decarboxylase (GAD) and 65 kD heat shock protein. We have detected two distinct antibody specificities in IDDM that bind 50,000 M, or 37,000/40,000 M, proteolytic fragments of 64,000 M, proteins. In this study, we investigated relationships of these proteolytic fragments to GAD and heat shock proteins. Polyclonal antibodies to GAD bound 50,000 M, fragments of islet antigen. Recombinant GAD65, but not GAD67, blocked binding to this antigen, suggesting that 50,000 M, fragments are derived from islet GAD65. In contrast, GAD antibodies did not recognize 37,000/ 40,000 M, fragments, and neither GAD isoforms blocked autoantibody binding to precursors of these fragments. The 37,000/40,000 M, fragments, but not the 50,000 M, fragments, were detected after trypsin treatment of immunoprecipitates from insulinoma cells that lacked expression of major GAD isoforms. Antibodies in IDDM did not bind native or trypsinized islet heat shock proteins. Thus, IDDM patients possess antibodies to GAD, but also distinct antibodies to a 64,000 M, protein that is not related to known GAD isoforms or heat -shock proteins. (J. Clin. Invest. 1993. 92:240-248.) 
Introduction
It is generally accepted that the specific destruction of pancreatic beta cells in insulin-dependent diabetes mellitus (IDDM)' is the result of an autoimmune response against one or more components of these cells (1) . Studies to characterize islet cell autoantigens associated with IDDM have identified one or more proteins ofMr-64,000 that are specifically immunoprecipitated by antibodies in sera from IDDM patients (2) (3) (4) . These proteins can associate with membranes and have amphiphilic properties, partitioning into a detergent phase on phase separa-tion in Triton X-114 (5) . The y-aminobutyric acid-synthesizing enzyme, glutamic acid decarboxylase (GAD) has been identified as a major 64,000 M, autoantigen in IDDM (6) .
GAD exists as multiple isoforms with different tissue-specific patterns of expression, membrane association, and reactivity with antibodies in diabetes (7) (8) (9) (10) . Two isoforms of GAD (GAD65 and GAD67) have been cloned and sequenced (9, 11) , and both isoforms are expressed in brain and islets (7, 8) .
GAD65 has similar membrane-binding properties to islet antigen (8) , and recombinant GAD65 has been shown to compete for autoantibody binding to islet 64,000 M, protein, suggesting that the lower molecular weight isoform is related to the islet antigen (12) .
By studying antibody binding to proteolytic fragments, we have identified two distinct antibody specificities to 64,000 Mr proteins in sera from IDDM patients (13) . Partial tryptic proteolysis of antigens immunoprecipitated from detergent extracts of islets generates three major fragments of Mr 50,000, 40,000, and 37,000. Diabetic patients possess antibodies to 50,000 M, fragments, and distinct antibodies that recognize both 40,000 M, and 37,000 M, fragments of antigen. Antibodies that bind the 50,000 Mr fragment (50k antibodies) also immunoprecipitate GAD from islet and brain extracts, whereas antibodies that bind 37,000 Mr and 40,000 M, fragments (37k antibodies) do not recognize GAD (10) . These 37k antibodies may recognize hidden determinants on GAD that are only exposed on trypsin cleavage, or may be directed to a protein distinct from GAD (10) .
We have previously suggested that the 50kand 37k-antibody specificities recognize determinants on different 64,000 Mr proteins (13) . Alternative candidate antigens in IDDM include a 65-kD heat shock protein (hsp 65). Both antibody and T cell reactivity to heat shock protein (hsp) 65 have been detected in the nonobese diabetic mouse model of IDDM (14, 15) and hsp 65 has been suggested to be a target for autoantibodies in human IDDM ( 16 ) . However, analysis ofbinding of antibodies in IDDM patients' sera to proteins in extracts of islets exposed to heat shock has failed to provide evidence for antibodies to islet heat shock proteins in the human disease ( 17) . The aim of this study was to clarify whether the 50,000 Mr, 40,000 Mr, and 37,000 Mr fragments of islet antigen are derived from distinct proteins and to investigate the relationships of these fragments to GAD and heat shock proteins.
Methods
Sera and antibodies. Sera from recent onset IDDM patients, obtained within 10 d of diagnosis of disease, or from normal healthy controls, were selected from previous studies on antibodies to islet cell antigens ( 10, 13, 18) . Serawere previously characterized forpresence ofantibodies to islet 64,000 Mr proteins ( 18) , to rat brain GAD ( 10) , and to tryptic fragments of islet antigen ( 13 ). Specific antibodies to GAD and heat shock proteins were also used in antigen characterization. These included a polyclonal sheep antiserum to purified rat brain GAD ( 19) , a rabbit antibody ( 1266) to a COOH-terminal 19-amino acid peptide of GAD67 ( [9] , gift of Dr. J. Petersen, Hagedorn Research Laboratory, Gentofte, Denmark), a rabbit antibody (5551) to a 14-amino acid peptide (VTWNPHKMMGVPLQ) spanning the pyridoxal phosphate binding site of GAD65 (gift of Prof. A. Lernmark, University of Washington, Seattle, WA) and a rabbit antiserum to Gro EL protein of Escherichia coli ([20] , gift of Dr. S. Hemmingsen, Plant Biology Institute, National Research Council, Saskatoon, Canada), which crossreacts with mammalian heat shock proteins hsp 65 and hsp 70. Normal sheep serum and normal rabbit serum (Sigma Immunochemicals, St. Louis, MO) were used as controls for these antibodies.
Islet and insulinoma cellpreparations. Islets from 5-7-d-old neonatal Wistar rats were prepared as previously described (21 Expression ofrecombinant GAD. COS-7 fibroblast cells were transfected with cDNA for rat islet GAD67 and endogenous proteins labeled with [35S]methionine as previously described (9) . BHK cells were transfected with cDNA for human GAD65 and GAD67 (22) and maintained as stable cell lines, 64/11 and K87-8, respectively. Cellular extraction and immunoprecipitation. Radiolabeled islets (2000-4000), insulinoma cells (2.5 x 107 cells) or COS cell transfectants were homogenized on ice by 20 passes of a motor-driven Teflon/ glass homogenizer (Wheaton Instruments, Millville, NJ) in 600 Al of 0.25 M sucrose, 10 mM Hepes (pH 7.4), 10 mM benzamidine, 0.1 mM p-chloromercuribenzene sulphonic acid, and 0.5% (wt/ vol) aprotinin. The homogenate was centrifuged at 10,000 g for 30 min at 4°C. The supernatant (Sl fraction) was collected and the pellet processed for phase separation in the detergent Triton X-1 14 or for trypsinization at 0.5 mg/ml trypsin (type XIII; Sigma Immunochemicals) as previously described (5, 13) .
Before immunoprecipitation, Triton X-1 14 extracts, SI fractions, or trypsin extracts were precleared with 50 ,l of normal human serum for 2 h at 4°C followed by binding to 100 Ml of protein A Sepharose (Sigma Immunochemicals) for 45 min at 4°C. A second preclearance was performed with 50 Ml of normal human serum for 18 h at 4°C and 100 Ml ofprotein A Sepharose for 45 min. Aliquots ofextract representing 5 X 106 cpm of radiolabeled protein in 50 Ml were incubated with 12.5 Ml ofserum from type 1 diabetic patients or control individuals, or 2 Ml of sheep or rabbit serum containing high titers of specific antibodies, for 5 h at 4°C. In competition experiments, Triton X-1 14 extracts of BHK cells transfected with GAD cDNA were added to radiolabeled islet extracts before incubation with sera. Immune complexes were isolated on 25 Ml (human sera) or 10 Ml (rabbit and sheep sera) of protein A Sepharose processed for SDS-PAGE on 12% polyacrylamide gels and for autoradiography as previously described (3) . In some experiments, immune complexes isolated on protein A Sepharose were incubated with 100 Ml of 0.1 mg/ml trypsin in 10 mM Hepes, 150 mM NaCl for 20 min at 4°C and washed with 1 ml of water before SDS-PAGE.
Where indicated, urea (8 M) was included in the sample buffer for SDS-PAGE.
Immunoprecipitation ofglutamate decarboxylase and trypticfragmentsfrom tissue extracts. Tissue contents of GAD, and the ability of antibodies in patients' sera to immunoprecipitate GAD enzyme activ-ity from brain, islets, or insulinoma cell extracts, were measured as previously described (10) .
The ability of sera to recognize GAD immunoreactivity, or tryptic fragments of GAD, from rat brain was analyzed by Western blotting. Soluble extracts of brain containing intact GAD were prepared as described ( 10) . Trypsin extracts of brain were prepared by homogenizing brains from two Wistar rats in 5 ml of 0.25 M sucrose, 10 mM Hepes (pH 7.4), 10 mM benzamidine, 0.1 mM p-chloro mercuribenzene sulphonic acid, 5 mM phenylmethylsulfonyl fluoride and particulate material sedimented at 10,000 g for 30 min. Pellets were washed once in 3 ml of 10 mM Hepes (pH 7.4), 150 mM NaCl, 10 mM benzamidine, 5 mM phenylmethylsulfonyl fluoride and twice in 3 ml of 10 mM Hepes (pH 7.4), 150 mM NaCl. Pellets were extracted in 12 ml of 10 mM Hepes (pH 7.4), 150 mM NaCl, 0.5 mg/ml trypsin for 30 min on ice and the reaction stopped by the addition of phenylmethylsulfonyl fluoride to 5 mM. Nonextracted material was removed by centrifugation at 10,000 g for 15 min.
Soluble brain extracts or trypsin extracts of brain (50-Ml aliquots) were incubated with 12.5 Ml of serum for 5 h at 4°C. Immune complexes were isolated on protein A Sepharose, and washed and processed for SDS-PAGE as previously described (3) . Separated proteins were transferred electrophoretically to nitrocellulose (23) and nitrocellulose blots incubated with a 1:1000 dilution of rabbit antisera to GAD peptides. Antibody binding to proteins on nitrocellulose was visualized with an alkaline phosphatase-conjugated second antibody to rabbit IgG (Sigma Immunochemicals) with nitroblue tetrazolium/5-bromo-4chloro-3-indolyl phosphate as substrate.
Two-dimensional gel electrophoresis. Islet extracts were processed for two-dimensional gel electrophoresis, with isoelectric focusing in the first dimension and SDS-PAGE in the second dimension, by the method of Hochstrasser et al. (24) .
Protein content and protein synthesis. Protein contents of tissue homogenates were determined by the Biuret reaction (25) .
[35S]methionine incorporation into proteins was determined by spotting 5-,Ml aliquots of tissue homogenates onto filter papers and precipitating proteins in ice-cold 10% trichloroacetic acid. Filter papers were washed extensively in 10% trichloroacetic acid and subsequently in ethanol, dried, and radioactivity incorporated into precipitated material determined by scintillation counting.
Results
Binding ofantibodies to islet and brain antigens. During our studies on autoantibody binding to proteins in detergent extracts of islets, we observed that some IDDM patients who lacked antibodies to GAD were still able to immunoprecipitate proteins of Mr 64,000 ( Fig. 1 a, lane 1) . These proteins were resolved as a diffuse doublet on SDS-PAGE and appeared distinct from the dominant 64,000 Mr protein immunoprecipitated by sera containing GAD antibodies ( Fig. 1 a, lane 2). Analysis of antibody binding to tryptic fragments of islet antigen indicated that these GAD-antibody-negative patients lacked antibodies to 50,000 Mr fragments but possessed antibodies that recognized 37,000 and 40,000 Mr fragments ( Fig. 1 b, lane 1). Sera from patients positive for GAD antibodies immunoprecipitated 50,000 M, fragments from trypsin extracts of islets ( Fig. 1 b, lane 2) . These observations led us to investigate whether IDDM is associated with antibodies to 64,000 Mr proteins that are distinct from GAD.
We determined whether the different fragments of islet antigen were recognized by a polyclonal sheep antiserum to rat brain GAD. Fig. 2 a illustrates polypeptides immunoprecipitated from trypsin extracts of islets by antibodies in diabetic patients' sera or by the antiserum to GAD. Diabetic patients were identified with antibodies to the 50,000 Mr fragment of b. Trypsin extract Figure 1 . Autoantibody recognition of islet antigens. Sera from a GAD-antibody-negative IDDM patient (lanes 1), a GAD-antibody-positive patient (lanes 2) and a control subject (lanes 3) were used to immunoprecipitate proteins from detergent extracts (a) or trypsin extracts (b) of rat islets. Polypeptides immunoprecipitated were detected by SDS-PAGE and autoradiography. The Mrs of major polypeptides recognized by antibodies are marked. antigen ( Fig. 2 a, lane 1), antibodies to 37,000 and 40,000 Mr fragments of antigen ( Fig. 2 a, lane 2) and antibodies to all three fragments ( Fig. 2 a, lane 3) . These fragments were not recognized by control sera (Fig. 2 a, lane 4) . The antiserum to GAD immunoprecipitated only 50,000 Mr fragments and failed to recognize either 40,000 or 37,000 Mr fragments from the islet trypsin extract (Fig. 2 a, lane 5).
To further characterize relationships of the antigenic fragments to GAD, patients' sera were tested for their ability to immunoprecipitate GAD immunoreactivity from soluble or trypsin-treated rat brain extracts. Immunoprecipitated GAD polypeptides were visualized by Western blotting using an antibody raised to a COOH-terminal peptide of GAD67, which cross-reacts with GAD65 (9) . Serum from diabetic patients positive for antibodies to islet 50,000 Mr tryptic fragments also immunoprecipitated 64,000 Mr proteins with GAD immunoreactivity from soluble brain extracts (Fig. 2 b, lanes I and 3) , and 50,000 Mr tryptic fragments from trypsin extracts ofbrain (Fig. 2 c, lanes I and 3) . Sera containing only 37 k antibodies did not immunoprecipitate GAD immunoreactivity from soluble or trypsin extracts ofbrain ( Fig. 2 b, lane 2; Fig. 2 c, lane 2). Identical results were obtained in Western blotting experiments using an antibody raised to a peptide spanning the pyridoxal phosphate binding site of GAD65 (data not shown).
Thus, trypsin extracts of brain contain 50,000 M, fragments that are immunoprecipitated by antibodies in diabetic patients' sera and that bear determinants for antibodies raised to two distinct GAD peptides. Trypsinization ofbrain does not generate 40,000 and 37,000 Mr fragments recognized by these GAD antibodies.
The same sera were characterized for their ability to immunoprecipitate GAD67, or trypsin-treated GAD67, from extracts of COS fibroblasts transfected with rat islet GAD67 cDNA. Only one of the diabetic patients immunoprecipitated a 67,000 Mr protein from Triton X-l 14 extracts of COS cell transfectants ( Fig. 2 d , lane 1) that comigrated with a 67,000 M, protein immunoprecipitated by the sheep antiserum to GAD ( Fig. 2 dlane 5 ). The 37k-antibody-positive sera did not immunoprecipitate GAD67 (Fig. 2 d, lanes 2 and 3) . In an a. Islet trypsin extract 1 2 3 4 (62.5%) had antibodies that immunoprecipitated recombinant GAD67. No significant correlation was observed between the ability to immunoprecipitate GAD67 from COS cell transfectants and GAD enzyme activity from rat brain extracts (r = 0.477, P > 0.05; Spearman correlation) or 37,000 Mr tryptic fragments from islet extracts (r = 0.013, P > 0.5). Diabetic patients positive for antibodies to GAD67, and the sheep antiserum to GAD, also immunoprecipitated polypeptides of -57,000 Mr from trypsin extracts of the COS cell transfectants (Fig. 2 e, lanes I and 5) .
Studies were performed to determine whether recombinant human GAD65 or GAD67 can compete for binding with autoantibodies to rat islet antigens. Triton X-114 extracts of BHK cells containing the recombinant proteins were added to detergent phase extracts of [35S ] methionine-labeled islets before immunoprecipitation with diabetic patient's serum. Immunoprecipitates were treated with trypsin before gel electrophoresis to distinguish antibody binding to 50,000 Mr fragment-related and 37,000/40,000 M, fragment-related antigens. Addition of GAD65, but not GAD67, blocked binding of antibodies to proteins generating 50,000 Mr fragments on trypsinization (Fig.  3 ). GAD67 was ineffective even with sera strongly positive for antibodies to recombinant GAD67 (Fig. 3, patient 2) . Addition of the recombinant proteins had no effect on antibody binding to protein precursors of 40,000 and 37,000 M, fragments.
GAD and autoantigen expression in insulinoma cells. Analysis of antigen binding to antibodies in diabetic patients was extended to two transformed insulin-secreting cell lines, HIT-T 15 and RIN-SAH. GAD enzyme activity was detected in homogenates of both of these cell lines, at activities of 2.28±0.28 ptmol/16 h per g protein (n = 3) for HIT-T15 cells and 50 ->-3.04±0.53 Aimol / 16 h per g protein (n = 3) for RIN-5AH cells.
In parallel experiments GAD enzyme activities in rat brain and neonatal rat islets were 104.26 and 9.52 ztmol/ 16 h per g protein, respectively ( 10 ) . Sera from three diabetic patients determined to be strongly positive for antibodies to 50,000 M, fragments of antigen immunoprecipitated GAD enzyme activity from islet and brain extracts (Fig. 4) . In contrast, the GAD activities in HIT-T 15 and RIN-5AH cell extracts, adjusted to similar enzyme concentrations as those in islet and brain preparations, were not recognized by antibodies in the diabetic patients' sera ( Fig. 4) . In Western blot studies, antibodies to GAD peptides did not recognize 64,000 or 67,000 Mr polypeptides in extracts of RIN-5AH or HIT-T 15 cells (data not shown). Thus, GAD enzyme activity can be detected in insulinoma cell lines, but this activity is immunochemically distinct from the major isoforms of GAD expressed in brain and islets.
The ability ofantibodies to recognize polypeptides in detergent extracts of radiolabeled insulinoma cells was analyzed. Antibodies in sera from 37k-antibody-positive IDDM patients specifically immunoprecipitated a 64,000 M, protein from detergent phase purified extracts of RIN-5AH cells, detectable only when immune complexes were solubilized in the presence of 8 M urea (Fig. 5 ). Trypsinization of the immunoprecipitated protein before electrophoresis generated 37,000 and 40,000 Mr fragments, but not 50,000 Mr fragments (Fig. 5 ). Similar results were obtained with HIT-T 15 cells.
Competition experiments were performed to determine Brain for antibodies to GAD from rat brain; patient 2 was strongly positive for antibodies to recombinant GAD67 (patient 1 in Fig. 2) . whether insulinoma cell antigen can compete for autoantibody binding to fragments of islet antigen. Addition of trypsin extracts of unlabeled HIT-T1 5 cells blocked immunoprecipitation of 37,000 and 40,000 M, fragments from [35S]_ methionine-labeled islet extracts but did not affect binding to 50,000 Mr fragments. The insulinoma cells, therefore, contain proteins with similar antigenic properties to 37,000 Mr and 40,000 Mr islet fragments, but may lack proteins from which 50,000 M, fragments are derived.
RIN cells HIT cells Islets
Binding ofantibodies to islet proteins after heat shock treatment. To investigate possible relationships of islet 64,000 Mr autoantigens to heat shock proteins, antibody reactivity to intact and trypsin-treated islet antigens was investigated in islets exposed to heat shock. Islets were incubated at 37°C (control) or 44°C (heat shock) for 20 min before labeling islet proteins with [3S]methionine. Incorporation of [35S] methionine into trichloroacetic acid-precipitable protein in heat shock treated islets was 93.7±2.96% (mean±SEM, n = 4) of the incorporation at 37°C. Two-dimensional gel electrophoresis ofislet proteins revealed considerable increases in the intensities of proteins of Mr 110,000, 90,000, 70,000, and 62,000 after heat shock (Fig. 6 ). Incorporation of label into most other individual proteins was similar under control and heat shock conditions.
The greater proportion ofproteins stimulated by heat shock were recovered in the supernatant (S 1 ) fraction after centrifuga-tion of islet homogenates. Immunoprecipitation experiments with SI fractions were performed to determine the ability of antibodies to recognize proteins induced by heat shock. A polyclonal rabbit antibody to Gro EL protein, the E. coli homologue ofhsp 65, immunoprecipitated 62,000 Mr and 70,000 Mr islet proteins stimulated by heat shock treatment (Fig. 7) . The 62,000 Mr hsp was not immunoprecipitated by antibodies in serum from a recent onset IDDM patient; similar results were obtained with five other IDDM patients. In experiments with extracts from heat shock-treated islets, 70,000 M, hsp was associated with immunoprecipitates with all control and diabetic sera tested. Similar nonspecific binding of hsp 70 to immune complexes has been observed in other immunoprecipitation studies (26). A 67,000 Mr protein was immunoprecipitated from Sl fractions of islets incubated at 37°C by antibodies in 3 of the 6 IDDM patients' sera tested, but not from extracts of heat shock-treated islets (Fig. 7) .
Detergent phase fractions from islets preincubated at 37°C or 44°C were used in immunoprecipitation experiments to determine the effect ofheat shock on islet antigen expression. The 64,000 Mr antigen migrated at a slightly higher Mr than the 62,000 Mr hsp (Fig. 7) . The recovery ofradiolabeled 64,000 Mr antigen was reduced in experiments with detergent phase extracts of islets preincubated at 44°C. Figure 6 . Islet protein expression after heat shock. Islets preincubated for 20 min at 370C or 440C were labeled with [35S]methionine for 5 h. Proteins in cytosolic (SI ) fractions were separated by isoelectric focusing (IEF,first dimension) and SDS-PAGE (second dimension) and radiolabeled proteins detected by autoradiography. The Mrs (X 10-3) of major proteins where [35S] methionine incorporation was stimulated by heat shock is indicated. tryptic fragments after heat shock. The recovery of immunowas relatively unchanged (Fig. 7) . Densitometric scanning of precipitable 50,000 Mr fragment of antigen was reduced after bands on autoradiograms representing immunoprecipitated heat shock, whereas recovery of 37,000 M, tryptic fragment polypeptides indicated a reduction in 50,000 M, fragment after SI fraction 370C 0`. -heat shock to 9.59±1.50% (mean±SEM) ofthat under control conditions, whereas the density of 37,000 Mr bands was 89.9±10.7% of control conditions (n = 4; P < 0.01, paired t test).
Discussion
We have previously shown that mild trypsin digestion of islet proteins immunoprecipitated by antibodies in IDDM generates three major fragments of M, 50,000, 40,000, and 37,000 ( 13) . By analyzing antibody reactivity to these fragments, we have detected antibodies in sera from IDDM patients that recognize 50,000 Mr fragments and distinct antibodies that recognize common determinants on the 40,000 and 37,000 Mr fragments. We have speculated that these fragments are derived from more than one 64,000 M, protein ( 13) . GAD has been identified as a major 64,000 Mr antigen (6); other authors have suggested that heat shock proteins might be antigens in IDDM (14) (15) (16) . In this study, we have determined whether these fragments are indeed derived from distinct proteins and have investigated possible relationships between the fragments of islet antigen, GAD, and heat shock proteins.
There is strong evidence that the 50,000 Mr component is derived from GAD. We have previously observed a high degree of correlation between the ability of antibodies to immunoprecipitate a GAD enzyme activity from rat brain extracts and the ability ofantibodies to bind 50,000 Mr tryptic fragments ofislet antigen ( 10) . In this study, a polyclonal sheep antiserum raised to brain GAD immunoprecipitated 50,000 Mr tryptic fragments that comigrated on SDS-PAGE with 50,000 Mr fragments recognized by antibodies in IDDM. Furthermore, sera containing antibodies to 50,000 Mr fragments of islet antigen also immunoprecipitated fragments ofidentical size from trypsin extracts ofbrain that were recognized by antibodies to GAD peptides. In a study by Baekkeskov et al. (6) , trypsin treatment was shown to generate 55,000 Mr immunoreactive fragments from both islet and brain GAD, and these 55,000 Mr polypeptides may be equivalent to the 50,000 M, fragments observed in our study. These data suggest that the 50,000 Mr component of antigen is a tryptic polypeptide of GAD that includes the COOH-terminal domain of the enzyme. Addition of recombinant GAD65 blocked binding ofantibodies to proteins, generating 50,000 Mr fragments on trypsinization. Addition ofrecombinant GAD67 did not affect binding, even with sera shown to be strongly positive for antibodies to GAD67. The results suggest that the 50,000 Mr fragment is derived from the lower Mr isoform of GAD, GAD65.
The 37,000 and 40,000 Mr fragments appear to be derived from a different protein to that generating 50,000 Mr fragments, since we found differences in the expression of the precursors to these fragments in islets and insulinoma cells. Thus, precursors of 37,000 and 40,000 Mr fragments were clearly present in extracts of insulinoma cell lines that lacked precursors of 50,000 Mr fragments, and in normal islets heat shock treatment reduced synthesis of 50,000 Mr fragments by more than 90%, but had little effect on synthesis of 37,000 and 40,000 Mr fragments. The results therefore support our suggestion that there is more than one 64,000 Mr autoantigen in IDDM.
Since GAD67 has also been reported to bind antibodies in IDDM (8, 9) , we investigated whether the 37,000 and 40,000 Mr fragments are derived from this second GAD isoform. Our findings suggest that GAD67 is not a target for 37k antibodies. The 37,000 and 40,000 Mr fragments were not recognized by the sheep antiserum to GAD, indicating either that they are derived from a non-GAD protein or that trypsin cleavage destroys determinants recognized by this polyclonal antibody.
Neither recombinant GAD65 nor GAD67 competed for autoantibody binding to precursors of 37,000 and 40,000 Mr fragments. No correlation was observed between the ability ofantibodies to recognize recombinant GAD67 and the 37,000/ 40,000 Mr tryptic fragments and trypsinization ofrecombinant GAD67 generated 57,000 Mr polypeptides and not 37,000 and 40,000 Mr fragments. Finally, the RIN insulinoma cell line has been shown to lack expression of both high and low molecular weight isoforms of GAD (27) , and in our experiments neither GAD immunoreactivity nor GAD mRNA were detectable in HIT or RIN cells by Western blotting with anti-GAD peptide antibodies or by Northern blotting with GAD cDNA probes (data not shown). A GAD enzyme activity was detected in insulinoma cell lines, but this GAD was not recognized by antibodies in IDDM. Despite the failure to detect GAD65 or GAD67 in RIN and HIT cells, precursors to 37,000 and 40,000 Mr antigenic fragments were clearly present in these cells. Together, these results provide strong evidence that the 37,000 and 40,000 Mr fragments are derived from proteins distinct from both GAD65 and GAD67.
The precursors of the 37,000 and 40,000 Mr antigen fragments do appear to be proteins of Mr 64,000. Diffuse bands at this Mr were immunoprecipitated from islet extracts by GADantibody-negative, 37k-antibody-positive sera. We, and others, have consistently failed to detect proteins of Mr other than 64,000 specifically immunoprecipitated by IDDM sera (28). Two-dimensional electrophoresis of the eluted immune complexes resolves 64,000 Mr proteins as multiple spots; two components (a and f3) display charge heterogeneity and have identical mobility on gels to a and 3 components ofGAD65 (6, 28) . A third protein, designated y, with identical Mr to the 3 component, but more negatively charged, has also been reported (29) . Analysis of the relationship of the y-component to 37,000 and 40,000 M, fragments requires specific antibodies to the protein, which are currently not available.
Diffuse bands of Mr 64,000 were also immunoprecipitated from extracts of RIN cells. However, these bands were detected only when immune complexes were solubilized in the presence of urea, and the bands were weaker than the 37,000 and 40,000 fragments observed on digestion of immune complexes with trypsin before electrophoresis (Fig. 5 ). We have previously observed that only weak bands could be detected by SDS-PAGE of immunoprecipitates from detergent extracts of islets with some sera strongly positive for 37k antibodies, and have suggested that 37k antibodies may be directed to determinants that are hidden on the detergent solubilized protein ( 13 ) . However, the results of the present study show that the native antigen is indeed recognized by 37k antibodies, since precursors of the 37,000/40,000 Mr fragments were clearly present in immunoprecipitates of detergent extracts from RIN cells. The difficulty in detecting nonproteolyzed antigen appears to be related to poor solubilization of immune complexes for gel electrophoresis, rather than poor antibody recognition. Urea, a strong denaturant, improved solubilization but bands were weak compared with those seen after proteolysis. Trypsin treatment may remove hydrophobic domains that might impair solubilization or may assist in dispersing protein aggregates.
Another potential target for antibodies in diabetes is hsp 65. However, consistent with an earlier report (17) , the islet 64,000 Mr proteins immunoprecipitated by antibodies in diabetes migrated at a slightly higher Mr than a 62,000 Mr islet heat shock protein, and antibodies in sera from diabetic patients did not specifically recognize heat shock proteins in extracts of islets. Furthermore, the 37,000:40,000 M, fragments do not appear to be related to heat shock proteins, since [35S]methionine incorporation into 37,000 M, antigenic fragments was not stimulated by heat shock. Polyclonal antibodies to hsp 65 did not cross-react with 37,000 Mr fragments. These observations provide further evidence against a role for islet heat shock proteins as targets for autoantibodies in human IDDM, either in native form or after proteolysis. The results do not exclude, however, an association of IDDM with cellular immunity to heat shock proteins or that autoimmunity to islet antigens might arise through cross-reactivity to epitopes on foreign heat shock proteins.
With the exception of heat shock proteins, the synthesis of most islet cell proteins was little affected by heat shock. However, heat shock treatment caused a dramatic decrease in the expression of the GAD component of antigen. This finding, together with the failure of insulinoma cell lines to express the GAD antigen, indicates that islet GAD has an exquisite sensitivity to downregulation by a number of factors. Downregulation of GAD expression in vivo might have important consequences for maintenance of immunological tolerance to the protein. A reduced expression in early life ofproteins expressed specifically by pancreatic beta cells has been shown to result in failure to induce immunological self-tolerance (30) . Downregulation of GAD during early development may result in impaired tolerance to the protein and increased susceptibility to autoimmune responses. Further studies on the regulation of GAD expression in pancreatic beta cells may provide important information relevant to the initiation of autoimmune responses to the protein in IDDM.
The identification of GAD65 as an autoantigen in IDDM is a major advance toward our understanding of autoimmunity to beta cells in the disease. However, the results of this study suggest that there is more than one 64,000 Mr protein autoantigen in IDDM and antibodies to 37,000 and 40,000 M, fragments are directed to a protein that is distinct from known GAD isoforms. The importance of this protein in IDDM is emphasized by studies in identical twins, where antibodies to 37,000 and 40,000 Mr fragments were found to be more closely associated with diabetes development than antibodies to GAD ( 31 ) . Detection of antibodies to this protein may therefore be particularly valuable in identifying individuals at risk for disease. Further characterization of the protein precursor to 37,000 and 40,000 Mr fragments and its relationship to GAD are critical to our understanding of the respective roles of these antigens in the immunopathogenesis of IDDM.
